Liabilities, Current of Universe Pharmaceuticals INC from 30 Sep 2020 to 30 Sep 2025
- Taxonomy & unit
- us-gaap: USD
- Description
- Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
- Summary
-
Universe Pharmaceuticals INC quarterly Liabilities, Current in USD history and change rate from 30 Sep 2020 to 30 Sep 2025.
- Universe Pharmaceuticals INC Liabilities, Current for the quarter ending 30 Sep 2025 was $13,173,930.
- Source SEC data
- View on sec.gov
Liabilities, Current, Quarterly (USD)
Liabilities, Current, YoY Quarterly Change (%)
Universe Pharmaceuticals INC Quarterly Liabilities, Current (USD)
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | $13,173,930 | -$20,299,795,070 | 30 Sep 2025 | 20-F | 29 Jan 2026 | 2025 | FY | |
| Q3 2024 | $20,312,969,000* | +$20,299,214,671 | 30 Sep 2024 | 20-F | 29 Jan 2026 | 2025 | FY | |
| Q1 2024 | $20,609,542 | -$2,632,118 | -11% | 31 Mar 2024 | 6-K | 20 Sep 2024 | 2024 | Q2 |
| Q3 2023 | $13,754,329 | +$656,777 | +5% | 30 Sep 2023 | 20-F | 29 Apr 2025 | 2024 | FY |
| Q1 2023 | $23,241,660 | +$13,033,781 | +128% | 31 Mar 2023 | 6-K | 31 Aug 2023 | 2023 | Q2 |
| Q3 2022 | $13,097,552 | +$1,887,124 | +17% | 30 Sep 2022 | 20-F | 30 Jan 2024 | 2023 | FY |
| Q1 2022 | $10,207,879 | 31 Mar 2022 | 6-K | 16 Aug 2022 | ||||
| Q3 2021 | $11,210,428 | +$3,209,034 | +40% | 30 Sep 2021 | 20-F | 10 Feb 2023 | 2022 | FY |
| Q3 2020 | $8,001,394 | 30 Sep 2020 | 20-F | 31 Jan 2022 | 2021 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.